Hey Madam...
As usual you are employing the good old selective reading and memory approach.
It was around August 2015 when Meso 1st tabled the Tier 1 & Tier 2 applications.
Tier 2s include Crohns ; Heart attack , spinal fusion and BMT. Since then ..at every presentation ( at least 10), it has been made very clear that the Company is concentrating on the following Tier 1’s
ALL $Bn dollar potential blockbuster
Plus
- CHF ( class 2-3 and Class 4)
- DDD
- RA
- aGVHD (where FDA agreed for a 60 patient open label trial)
In contrast BMT has a small $$n market application and reach. When you have limited cash, you allocate your dollars to the Blockbusters.
Having said that , once a partnering deal is done and there is strong cash flow ..just watch how BMT comes back with a vengeance as it is Meso’s mission to bring real change and hope to many sick patients suffering from a multitude of illnesses.
In regards to MNK and aGVHD ..as previously posted on the forum…the longer it goes for no deal , the greater the chance of no deal. WHY ? As the 60 patient (open label trial) is close to completion and 30 days after this we have the results , if the results are positive this will be a watershed moment for MSB , its holders, its non-holders and its patients. If not , then we holders still have the Tier1 applications as our back stop.
So what do you think Madam ?
Regarding 60 patient aGVHD application – YES , NO or I don’t know .
All answers fair ahead of the results.
GLTA.
- Forums
- ASX - By Stock
- MSB
- Back pain stem cell injection
Back pain stem cell injection, page-68
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online